Estrella Immunopharma, Inc. Quarterly Liabilities, Current in USD from Q3 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Estrella Immunopharma, Inc. quarterly Liabilities, Current history and growth rate from Q3 2021 to Q2 2024.
Estrella Immunopharma, Inc. Liabilities, Current for the quarter ending June 30, 2024 was $181K, a 98.1% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$181K	-$9.58M	-98.1%	Jun 30, 2024	10-K	2024-09-27
Q1 2024	$138K	-$1.08M	-88.6%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$399K	-$674K	-62.8%	Dec 31, 2023	10-Q	2024-02-14
Q3 2023	$17.3M	+$16.5M	+2249%	Sep 30, 2023	10-Q	2023-11-20
Q2 2023	$9.76M	+$9.6M	+6210%	Jun 30, 2023	10-K	2024-09-27
Q1 2023	$1.22M	+$1.19M	+3925%	Mar 31, 2023	10-Q	2023-05-18
Q4 2022	$1.07M	+$1M	+1367%	Dec 31, 2022	10-Q	2023-08-01
Q3 2022	$736K	+$635K	+631%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$155K			Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$30.2K			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$73.2K			Dec 31, 2021	10-K	2023-03-14
Q3 2021	$101K			Sep 30, 2021	10-Q	2021-11-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.